期刊文献+

紫杉醇对人树突状细胞的生物活性的影响 被引量:4

Effect of Paclitaxel on biological activity of human dendritic cells
下载PDF
导出
摘要 目的探讨常用化疗药物紫杉醇(TAX)对人树突状细胞(DC)生物活性的影响及作用机制,为化疗联合生物免疫治疗抗肿瘤提供理论基础。方法体外实验:分别在紫杉醇5 ng/mL(b组)、10 ng/mL(c组)、20 ng/mL(d组)、40 ng/mL(e组)的浓度下及不加紫杉醇的条件下(a组)培养DC细胞,检测各组DC细胞的存活率、细胞成熟标志物及细胞因子分泌量,探究紫杉醇对人树突状细胞生物活性的影响,同时通过乳酸脱氢酶释放法(LDH)测定与紫杉醇处理的树突细胞共培养的细胞因子诱导的杀伤细胞(CIK)对肺癌A549细胞株的杀伤作用,测定紫杉醇对树突细胞抗原呈递作用的影响。体内实验:采用人肺癌细胞株A549的肿瘤组织块,皮下接种于裸鼠腋下,建立裸鼠肺癌模型。2 d后将30只裸鼠随机分成5组,分别为A组(对照组):细胞株A549+盐水(NS);B组:细胞株A549+DC+CIK;C组:细胞株A549+CIK+TAX;D组:细胞株A549+TAX;E组:细胞株A549+TAX+DC+CIK。每3天检测1次肿瘤大小、裸鼠存活时间。结果体外实验:在共培养6 d的前提下,b、c组第6天存活率与第0天存活率比较,差异无统计学意义(P>0.05),d、e组第6天存活率与第0天存活率比较,差异有高度统计学意义(P<0.01),e组存活率仅为17.5%。c组和e组CD86、CD40、MHCⅡ的表达以及IL-12的分泌与正常组相比有显著增加(P<0.05),d组除了CD86,其他检测指标较正常组差异均有统计学意义,b组中只有MHCⅡ较正常组差异有统计学意义,经10 ng/mL紫杉醇处理的细胞在效靶比5:1和10:1的情况下,杀伤效果明显高于未经紫杉醇处理的细胞。其中紫杉醇处理组的细胞在效靶比为10:1的情况下,杀伤活性已经到达(91.37±5.24)%。体内实验:B、C、D、E组的平均存活时间分别为33.0、34.0、31.8、41.8 d,明显高于对照A组(23.8 d)(P<0.05)。E组平均存活时间大于41.8 d,明显高于B、C、D组(P<0.01),其中E组中,45 d仍有3只存活,D组在前25 d体现出较好的治疗效果 Objective To explore the biological activity's effect and mechanism of common chemotherapy drug Paclitaxel (TAX) on human dendritic cells (DC),and to provide a theoretical basis for the anti-tumor combination therapy of chemotherapy and immune therapy.Methods In vitro:DC were cultured separately without TAX (group a) and with different concentrations of TAX:5 ng/mL (group b),10 ng/mL (group c),20 ng/mL (group d),and 40 ng/mL (group e).In order to explore the effect of TAX on biological activity of DC,survival rates,cell maturation markers and cytokine secretion were detected.In order to explore the effect of TAX on DCs' antigen-presenting function,the cytotoxicity on the lung cancer cell line A549 of cytokine-induced killer cells (CIK),which were co-cultured with pre-treated dendritic cells with TAX,was determined by lactate dehydrogenase release assay.In vivo:lung cancer model of nude mice was established by subcutaneously inoculating human lung cancer cell line A549 tumor tissue blocks into nude mice armpit.Two days later,30 mice were randomly divided into five groups:group A (control group):cell line A549 + saline (NS),group B:cell line A549 + DC + CIK,group C:cell line A549 + CIK + TAX,group D:cell line A549 + TAX,and group E:cell line A549 + TAX + DC + CIK.The tumor size and the survival time of mice were examined every 3 days.Results In vitro:there was no statistical difference (P > 0.05) between the cell survival rates in group b and group c on the day 6 and that on day 0 after co-cultured 6 days.There was significant statistical difference (P < 0.01) between the cell survival rates in group d and group e on the day 6 and that on day 0 after co-cultured 6 days.The survival rate of DC in group e was only 17.5%.The expression of CD86,CD40 and MHC Ⅱ and the secretion of IL-12 in group c and group e increased significantly compared with control group.Those test results expect the expression of CD86 in group d were
出处 《中国医药导报》 CAS 2013年第33期15-19,共5页 China Medical Herald
基金 辽宁省科技厅 财政厅批准组建土木基础设施安全监测与控制等重点实验室(项目编号:辽科发[2011]20号)
关键词 紫杉醇 人树突状细胞 生物活性 肺癌 Paclitaxel Human dendritic cells Biological activity Lung cancer
  • 相关文献

参考文献14

  • 1沈洪兵,俞顺章.我国肺癌流行现状及其预防对策[J].中国肿瘤,2004,13(5):283-285. 被引量:139
  • 2Rosenberg SA,Yang JC,Restifo NP. Cancer immunotherapy: moving beyond current vaccines [J]. Nature Medicine, 2004,10 (9) :909-915. 被引量:1
  • 3Chang CL,Hsu YT,Wu CC,et al. Dose-dense chemotherapy improves mechanisms of antitumor immune response [J]. Can- cer Research, 2013,73 ( 1 ) : 119-127. 被引量:1
  • 4Schlom J. Therapeutic cancer vaccines:current status and mov- ing forward [J]. J Natl Cancer Inst,2012,104(8) :599-613. 被引量:1
  • 5Vander Most RG,Currie AJ,Robinson BW,et al. Decoding dan- gerous death :how cytotoxic chemotherapy invokes inflamma- tion,immunity or nothing at all [J]. Cell Death Differ,2008,15 : 13 -20. 被引量:1
  • 6Ramakrishnan R,Assudani D,Nagaraj S,et al. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice [J]. The Journal of Clin- ical Investigation, 2010,120(4) : 1111-1124. 被引量:1
  • 7Ding ZC,Blazar BR,Mellor AL,et al. Chemotherapy rescues tumor-driven aberrant CD4 + T-cell differentiation and re- stores an activated polyfunctional helper phenotype [J]. Blood, 2010,115 (12) : 2397-2406. 被引量:1
  • 8Linn YC,Hui KM. Cytokine-induced killer cells:NK-like T cells with cytotolytie specificity against leukemia [J]. Leukemia & Lymphoma ,2003,44(9) : 1457-1462. 被引量:1
  • 9Marten A,Renoth S,Von Lilienfeld-Toal M,et al. Enhanced lytie activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells [J]. Haematologiea, 2001,86(10) : 1029-1037. 被引量:1
  • 10Hart DN. Dendritic cells:unique leukocyte populations which control the primary immune response [J]. Blood, 1997,90 (9) : 3245-3287. 被引量:1

二级参考文献25

  • 1Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintière C, Daniel P, Genetet N, Meunier B, Dupont-Bierre E, Boudjema K, Catros V.Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors.Potential for immunotherapy of hepatocellular and colorectal carcinomas.Cancer Immunol Immunother 2008; 57: 531-539 被引量:1
  • 2Jameson JM, Cauvi G, Sharp LL, Witherden DA, Havran WL.Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation.J Exp Med 2005; 201: 1269-1279 被引量:1
  • 3Corvaisier M, Moreau-Aubry A, Diez E, Bennouna J, Mosnier JF, Scotet E, Bonneville M, Jotereau F.V gamma 9V delta 2 T cell response to colon carcinoma cells.J Immunol 2005; 175: 5481-5488 被引量:1
  • 4Coleman RE.Bisphosphonates: clinical experience.Oncologist 2004; 9 Suppl 4: 14-27 被引量:1
  • 5Watanabe N, Narita M, Yokoyama A, Sekiguchi A, Saito A, Tochiki N, Furukawa T, Toba K, Aizawa Y, Takahashi M.Type Ⅰ IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.Cytotherapy 2006; 8: 118-129 被引量:1
  • 6Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ.A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone.Paget's Risedronate/Etidronate Study Group.Am J Med 1999; 106: 513-520 被引量:1
  • 7Clézardin P.The antitumor potential of bisphosphonates.Semin Oncol 2002; 29 (6 Suppl 21): 33-42 被引量:1
  • 8李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 9陈复兴,刘军权,冯霞,王涛,张娟,张颂,陈桂林.人末梢血γδT细胞对消化系统肿瘤细胞的杀伤作用[J].世界华人消化杂志,2007,15(14):1591-1595. 被引量:20
  • 10Boffetta P, Trichopoulos D. Cancer of the lung, larynx,and pleura[A].Adami HO.Textbook of cancer epidemiology[M].England:Oxford University Press, 2002.248-273. 被引量:1

共引文献145

同被引文献37

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部